Danish EMA Chief puts spotlight on medicines of the future

Meet Steffen Thirstrup, Chief Medical Officer at the European Medicines Agency (EMA), at a special Regulatory Affairs event.

Get first-hand insights from one of Europe’s leading regulatory experts, hear his perspectives on the future of medicines and regulation, and join the conversation on the issues shaping Regulatory Affairs.

What will you gain from attending?
The topic for the session is: How will Europe shape the future of drug development and therapeutic innovation in an increasingly complex and rapidly changing world?

Drawing on his extensive experience across regulatory authorities, academia and industry, Steffen Thirstrup will share his perspective on:

- EMA’s future role in medicines regulation

- Evolving expectations for clinical evidence

- The growing role of real-world evidence

- EMA’s view on the potential for greater acceptance of a single pivotal trial

We will also hear an industry perspective from Lene Kjær Kirstein and Inka Heikkinen, Regulatory Science & Policy at Lundbeck. 

Programme

- 5.00–5.10 pm: Welcome by Pharmadanmark

- 5.10–5.55 pm: Presentation by Steffen Thirstrup from EMA

- 5.55–6.10 pm: Short break

- 6.10–6.30 pm: Industry presentation by Lene Kjær Kirstein and Inka Heikkinen from Lundbeck

- 6.30–7.00 pm: Panel discussion and Q&A

- 7.00–7.30 pm: Sandwiches and networking

Who can attend?
The event is exclusively for Pharmadanmark members.

Practical information
Sandwiches and refreshments will be served.

If you are attending online, you will receive a Microsoft Teams link shortly after registering.